Chronic hepatitis B: new therapies on the horizon?
- 1 November 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9191) , 1662-1663
- https://doi.org/10.1016/s0140-6736(99)00305-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virusHepatology, 1999
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- Specific Vaccine Therapy in Chronic Hepatitis B: Induction of T Cell Proliferative Responses Specific for Envelope AntigensThe Journal of Infectious Diseases, 1999
- Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.Journal of Clinical Investigation, 1998
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Global status of hepatitis B immunisationThe Lancet, 1996
- Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis BNew England Journal of Medicine, 1996
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BAnnals of Internal Medicine, 1993